Neurological
|
March 6, 2025

Synergistic Action of Serdexmethylphenidate and Dexmethylphenidate in ADHD Treatment

Medically Reviewed by
Updated On
March 26, 2025

Did you know that approximately 5% of the global population lives with ADHD? Despite increasing awareness, finding an effective treatment can still be frustrating. Many individuals experience trial and error, as what works for one person may not work for another.

One approach involves combining serdexmethylphenidate and dexmethylphenidate (Azstarys). This combination has shown promise in helping some individuals manage their ADHD symptoms.

This article explores ADHD, the potential benefits of combining these medications, addresses common misconceptions, and offers guidance for patients and caregivers in navigating ADHD treatment options with their healthcare provider.

[signup]

Understanding ADHD and Its Challenges

Attention-Deficit/Hyperactivity Disorder (ADHD) is a condition that affects both children and adults, making it challenging to focus, control impulses, and manage hyperactivity. Symptoms can vary widely among individuals, but they generally fall into three categories:

  • Inattention: Difficulty staying focused, completing tasks, and following instructions.
  • Hyperactivity: Excessive energy, such as fidgeting or being unable to sit still.
  • Impulsivity: Acting without thinking, interrupting others, or making hasty decisions.

While ADHD is often diagnosed in childhood, many individuals may not be diagnosed until later in life. In the U.S., approximately 6 in 10 children with ADHD have moderate to severe symptoms, and over 15 million adults are affected. ADHD can impact all areas of life, including education, work, relationships, and personal well-being, and finding an effective treatment can be challenging and time-consuming.

Impact on Daily Life and Long-Term Outcomes


ADHD can create significant obstacles in academic, social, and professional settings:

  • Students may struggle with organization, completing assignments, and meeting deadlines in school. These challenges can affect performance and self-esteem, leading to difficulties in achieving their full potential.

  • Socially, ADHD can make it challenging to maintain friendships. Impulsivity and distractibility may result in interrupting conversations, forgetting important details, or having trouble staying engaged with others.

  • In the workplace, adults with ADHD often face challenges in meeting deadlines, managing time effectively, and staying organized, which can affect their career growth. Maintaining professional relationships can also be difficult due to difficulties with attention and impulsivity.

Long-term, untreated ADHD can increase the likelihood of developing other mental health concerns, such as anxiety or depression, as individuals may feel frustrated by these ongoing challenges.

Current Treatment Landscape

ADHD treatment typically involves medications and behavioral therapies, but these approaches each have limitations.

Common Medications and Therapies

Medications are often the first line of treatment, with stimulants like methylphenidate and amphetamines being the most widely prescribed. They can help improve focus and manage hyperactivity by increasing the levels of certain neurotransmitters in the brain. For those who don't respond well to stimulants, non-stimulant medications are available, though they generally take longer to show effects.

Behavioral therapies, including cognitive-behavioral therapy (CBT), social skills training, and parent training, are commonly used alongside medications. These therapies focus on developing coping strategies, improving organizational skills, and managing impulsive behaviors.

Limitations and Gaps in Existing Treatments

Medications and therapies can be effective, but their results may vary between individuals. Finding the proper medication or dosage often requires time and adjustments, and side effects may limit their use for some patients. Behavioral therapies, though helpful, typically require ongoing effort and may not produce lasting results without continued support. Additionally, access to therapy can be challenging due to factors like cost or availability.

Serdexmethylphenidate and Dexmethylphenidate

Although similar, these medications have distinct properties that, when combined, may provide symptom relief for some individuals. Consult your doctor to determine if this combination is the right treatment.

What Are These Medications?

Both serdexmethylphenidate and dexmethylphenidate are medications used to help manage ADHD symptoms. They belong to a class of drugs called central nervous system (CNS) stimulants, which affect brain chemicals that regulate focus, attention, and impulse control.

Dexmethylphenidate

Dexmethylphenidate works by increasing the activity of two essential brain chemicals: dopamine and norepinephrine. These chemicals help improve concentration, focus, and impulse control. This medication acts quickly, providing immediate relief for some ADHD symptoms. 

For many individuals, it works well with fewer side effects than other stimulant medications. However, some individuals may experience side effects like insomnia or appetite loss.

Serdexmethylphenidate

Serdexmethylphenidate, on the other hand, is a type of medication that works a little differently. It's a "prodrug," meaning it doesn't become active right away. The body needs to process it first, turning it into the active form of the medication. 

This slower activation allows for a more gradual and longer-lasting effect, which can help maintain symptom control throughout the day. It may be an option for those who need extended symptom relief or experience side effects from faster-acting stimulants.

These medications help balance the brain's chemical activity, providing a more stable symptom management approach.

Why Combine Them?

Combining serdexmethylphenidate and dexmethylphenidate (SDX/d-MPH) can offer synergistic effects, meaning the combination may provide better symptom relief for some individuals than when used separately. Together, they can improve focus, attention, and impulse control more consistently and for extended periods.

This combination may offer:

  • Consistent symptom control: The gradual release from serdexmethylphenidate offers smooth, lasting relief, while dexmethylphenidate’s quick action helps manage symptoms effectively during the day.

  • Improved outcomes: The combination can provide more balanced and reliable results by reducing fluctuations in symptom control.

  • Personalized treatment: This approach allows healthcare providers to tailor ADHD treatment based on an individual's specific needs, enhancing safety and effectiveness.

Evidence-Based Benefits of the Combination

When evaluating the effectiveness of SDX/d-MPH, researchers assess three key factors: 

  1. Efficacy: How well does the combination improve ADHD symptoms, such as focus, impulse control, and hyperactivity?

  2. Safety: How safe is the combination, and are there any significant side effects?

  3. Tolerability: How easily can individuals handle the medication without experiencing significant discomfort or adverse effects?

These studies aim to address these key metrics.

Clinical Studies and Results

Several clinical studies have explored the effectiveness and tolerability of SDX/d-MPH in treating ADHD. Early data suggests that SDX, a prodrug of dexmethylphenidate, offers a longer duration of action compared to other stimulant medications. Its prodrug design may help reduce the risk of misuse, as it needs to be metabolized by the body before becoming active. Additionally, the medication can be opened and sprinkled, making it easier for individuals who have difficulty swallowing pills. The side effects are similar to other stimulant medications, and overall, SDX/d-MPH is considered safe.

A 12-month double-blind safety study in children aged 6-12 years showed that SDX/d-MPH was well tolerated and had similar effects to other ADHD treatments. A post-study analysis focused on growth showed small, non-significant changes in weight and height over the 12 months, with minor decreases in Z-scores (a measure comparing a child's growth to others of the same age and sex). These changes were not clinically significant, and the long-term use of SDX/d-MPH was associated with only minimal reductions in weight gain and slower increases in height. These effects plateaued over time.

Other research evaluated SDX/d-MPH's effectiveness in children aged 6-12 over 21 days. After an initial dose, the dosage was adjusted to find the optimal level for each child. The results showed that most children experienced significant improvements in ADHD symptoms. Specifically, 80% of children on the lowest dose, 81.2% on the middle dose, and 72.4% on the highest dose saw at least a 50% improvement. These findings suggest that SDX/d-MPH is effective in reducing ADHD symptoms and that adjusting the dose based on individual needs helps create an optimal treatment plan.

Another randomized, double-blind study compared SDX/d-MPH to a placebo in children aged 6-12, assessing its effects on ADHD symptoms. After a dose adjustment phase, children either received the optimal dose of SDX/d-MPH or a placebo for seven days. Results showed that SDX/d-MPH significantly improved ADHD symptoms and enhanced focus for up to 13 hours. The most common side effects were difficulty sleeping and decreased appetite, but no serious side effects were reported. Overall, SDX/d-MPH proved to be an effective and safe treatment option with lasting benefits.

Results may vary; individuals should consult their healthcare provider to determine the best treatment.

Addressing Concerns and Misconceptions

It's natural to have concerns when considering ADHD medications. Let's address some of these common misconceptions.

Potential Side Effects

Like all medications, SDX/d-MPH can cause side effects. Some of the more common ones include:

  • Insomnia
  • Decreased appetite
  • Headaches
  • Dizziness
  • Nausea
  • Increased heart rate

These side effects are often manageable with the help of a healthcare provider, who can adjust the treatment plan if needed.

Myths About ADHD Medications

There are several misconceptions about ADHD medications that can contribute to stigma. Here are a few to consider:

Myth 1: ADHD Medications Are Only for Children

ADHD is often diagnosed in childhood, but it can continue into adulthood. Many adults benefit from medication as part of their treatment plan.

Myth 2: ADHD Medications Are Addictive

Misuse of any medication can be harmful. However, when prescribed, these medications are generally safe and effective. Proper usage and regular check-ups help prevent misuse.

Myth 3: ADHD Medications Change Your Personality

When used correctly, ADHD medications should help individuals feel more focused and in control without affecting their personality. The goal is to help people manage their symptoms and function more effectively in daily life, not change who they are.

Myth 4: You Can Just Stop Taking ADHD Medications Anytime

Suddenly stopping medication can cause withdrawal symptoms or a return of ADHD symptoms. Always follow your healthcare provider's advice when adjusting or discontinuing medication.

Guidance for Patients and Caregivers

Successful ADHD treatment relies on clear communication and ongoing monitoring. Collaborating with your healthcare provider ensures your treatment plan is personalized and effective.

How to Talk to Your Doctor

When starting a new treatment plan, it's important to have open discussions with your healthcare provider. Here are some questions to guide your conversation:

  1. How do these medications work together for my symptoms?
  2. What side effects should I expect?
  3. What's the best way to take these medications?
  4. How will we track progress?
  5. Are there alternative treatment options?

Monitoring Progress

Once treatment begins, it's important to track both the effectiveness of the medications and any side effects. Here's how to monitor progress:

  • Keep a daily log: Record your symptoms, side effects, and how you feel throughout the day. Note any changes in focus, energy levels, impulse control, or sleep patterns.

  • Monitor emotional well-being: ADHD symptoms can impact emotional health, so tracking your mood is important for assessing treatment progress.

  • Regular follow-ups: Schedule check-ins with your doctor to assess treatment and adjust as needed.

By actively monitoring your progress and maintaining open communication with your healthcare provider, you can work together to find the best treatment plan.

Always follow your healthcare provider's guidance when starting or adjusting any treatment plan.

[signup]

Key Takeaways

  • The combination of serdexmethylphenidate and dexmethylphenidate may offer more balanced and lasting relief from ADHD symptoms by providing both immediate and extended effects on focus, attention, and impulse control.
  • ADHD treatment is personalized, and what works for one individual may not be effective for another. Collaborating with your healthcare provider helps ensure the treatment plan is tailored to your specific needs.
  • If you're considering this medication combination or exploring other treatment options, consult your healthcare provider for more information and guidance in finding the best solution.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Achuff, J. (2024a, February 22). Understanding ADHD: A Deep Dive into the Brain’s Structure. Rupa Health. https://www.rupahealth.com/post/understanding-adhd-a-deep-dive-into-the-brains-structure

Achuff, J. (2024b, April 8). Unveiling the Hidden Link: Sleep Disordered Breathing and ADHD. Rupa Health. https://www.rupahealth.com/post/unveiling-the-hidden-link-sleep-disordered-breathing-and-adhd

Anderson, S. (2022, September 21). 10 Commonly Prescribed Medications & The Nutrients They Deplete. Rupa Health. https://www.rupahealth.com/post/10-commonly-prescribed-medications-the-nutrients-they-deplete

Barnhardt, E. A., Narayanan, A. R., & Coury, D. L. (2023). Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD. Expert Opinion on Pharmacotherapy, 24(11), 1215–1219. https://doi.org/10.1080/14656566.2023.2218544

Bertagna, B., & Kresge, K. (2024a, February 14). A Comprehensive Guide To Side Effects and Drug-Nutrient Interactions Of ADHD Medication. Rupa Health. https://www.rupahealth.com/post/a-comprehensive-guide-to-side-effects-and-drug-nutrient-interactions-of-adhd-medication

Bertagna, B., & Kresge, K. (2024b, February 14). Exploring Mind-Body Interventions for ADHD Symptom Management. Rupa Health. https://www.rupahealth.com/post/exploring-mind-body-interventions-for-adhd-symptom-management

Bertagna, B., & Kresge, K. (2024c, February 14). Nutrients for Focus and ADHD: Exploring the Link Between Nutrition and Symptoms. Rupa Health. https://www.rupahealth.com/post/nutrients-for-focus-and-adhd-exploring-the-link-between-nutrition-and-symptoms

Bertagna, B., & Kresge, K. (2024d, February 14). The Rising Incidence of ADHD: The Prevalence and Potential Impact. Rupa Health. https://www.rupahealth.com/post/the-rising-incidence-of-adhd-the-prevalence-and-potential-impact

Bryant, A. (2025, February 17). How the ADHD Medication Shortage Impacts Patients. Rupa Health. https://www.rupahealth.com/post/how-the-adhd-medication-shortage-impacts-patients

CDC. (2024a, May 15). Data and Statistics on ADHD. Attention-Deficit / Hyperactivity Disorder (ADHD); CDC. https://www.cdc.gov/adhd/data/index.html

CDC. (2024b, May 15). Medication Safety and Your Health. Medication Safety Program. https://www.cdc.gov/medication-safety/about/index.html

CDC. (2024c, October 23). About attention-deficit / hyperactivity disorder (ADHD). Attention-Deficit / Hyperactivity Disorder (ADHD); CDC. https://www.cdc.gov/adhd/about/index.html

Central Nervous System: What Does It Do? (2023). Cleveland Clinic. https://my.clevelandclinic.org/health/body/central-nervous-system-cns#overview

Childress, A. C., Cutler, A. J., Patel, M., & Oh, C. (2023). Analysis of Growth Velocity in Children with Attention-Deficit/Hyperactivity Disorder Treated for up to 12 Months with Serdexmethylphenidate/Dexmethylphenidate. Journal of Child and Adolescent Psychopharmacology, 33(4), 134–142. https://doi.org/10.1089/cap.2023.0012

Cloyd, J. (2023a, June 22). Optimal Lab Testing for Adult ADHD: Unveiling the Top 6 Specialty Labs to Enhance Patient Assessment and Treatment. Rupa Health. https://www.rupahealth.com/post/top-6-labs-for-adults-with-adhd

Cloyd, J. (2023b, September 25). Integrative Approaches to Supporting Mental Health In Chronic Conditions. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-supporting-mental-health-in-chronic-conditions

Cloyd, J. (2023c, December 15). How to Interpret a Neurotransmitter Test. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-a-neurotransmitter-test

Cloyd, J. (2024a, March 13). What is Dopamine’s Role in ADHD? Rupa Health. https://www.rupahealth.com/post/what-is-dopamines-role-in-adhd

Cloyd, J. (2024b, June 6). 5 Medications That May Be Interfering with Your Sleep. Rupa Health. https://www.rupahealth.com/post/medications-interfering-with-sleep

Cloyd, J. (2024c, September 17). Enhancing Psychological Wellbeing Through Exercise: The Role of Self-Esteem. Rupa Health. https://www.rupahealth.com/post/enhancing-psychological-wellbeing-through-exercise-the-role-of-self-esteem

Coleman, E. (2025, February 19). Alcohol Withdrawal: Insights into Delirium Tremens. Rupa Health. https://www.rupahealth.com/post/alcohol-withdrawal-insights-into-delirium-tremens

Creedon, K. (2022, August 4). 6 speciality labs that get to the root cause of insomnia. Www.rupahealth.com. https://www.rupahealth.com/post/6-speciality-labs-that-get-to-the-root-cause-of-insomnia

Cutler, A. J., Kollins, S. H., Brams, M. N., Corliss, M., Oh, C., Braeckman, R., & Childress, A. C. (2024). Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study. Frontiers in Psychiatry, 15. https://doi.org/10.3389/fpsyt.2024.1310483

Drug Efficacy - an overview | ScienceDirect Topics. (2019). Www.sciencedirect.com. https://www.sciencedirect.com/topics/medicine-and-dentistry/drug-efficacy

Gerow, S. (2024, March 13). Top Pediatric Labs To Run On Your Patients Annually. Rupa Health. https://www.rupahealth.com/post/top-pediatric-labs-to-run-on-your-patients-annually

Johns Hopkins Medicine. (2024). Help for Managing Multiple Medications. Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/wellness-and-prevention/help-for-managing-multiple-medications

Kollins, S. H., Braeckman, R., Guenther, S., Barrett, A. C., Mickle, T. C., Oh, C., Marraffino, A., Cutler, A. J., & Brams, M. N. (2021). A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 31(9), 597–609. https://doi.org/10.1089/cap.2021.0077

Kresge, K. (2022, February 2). How Mike Used Diet And Nutrition To Reduce His ADHD Symptoms. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-adhd

Kresge, K. (2023, March 2). An Integrative Medicine Approach to ADHD. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-adhd

Mayo Clinic. (2025, February). Cognitive Behavioral Therapy. Mayoclinic.org; Mayo Clinic. https://www.mayoclinic.org/tests-procedures/cognitive-behavioral-therapy/about/pac-20384610

MedlinePlus. (2022). Methylphenidate: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a682188.html#why

MedlinePlus. (2023). Amphetamine: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a616004.html#why

MedlinePlus. (2024a). Dexmethylphenidate: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a603014.html#why

MedlinePlus. (2024b). Serdexmethylphenidate and Dexmethylphenidate: MedlinePlus Drug Information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a621026.html#why

MedlinePlus. (2024c). Taking medicines - what to ask your provider: MedlinePlus Medical Encyclopedia. Medlineplus.gov. https://medlineplus.gov/ency/patientinstructions/000535.htm

National Institute of Mental Health. (2024). Attention-Deficit/Hyperactivity disorder: What you need to know. National Institute of Mental Health (NIMH). https://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder-what-you-need-to-know

Norepinephrine: What it is, function, deficiency & side effects. (2022, March 27). Cleveland Clinic. https://my.clevelandclinic.org/health/articles/22610-norepinephrine-noradrenaline

Preston, J. (2023a, May 2). Complementary and Integrative Medicine Testing and Treatment for Children with ADHD. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-for-the-treatment-of-adhd-in-children

Preston, J. (2023b, August 4). Top Labs To Run Bi-Annually On Your Patients Who Suffer From Attention-Deficit/Hyperactivity Disorder (ADHD). Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-patients-who-suffer-from-attention-deficit-hyperactivity-disorder-adhd

Preston, J. (2023c, October 24). The Top 5 Natural Remedies for ADHD. Rupa Health. https://www.rupahealth.com/post/the-top-5-natural-remedies-for-adhd

Prodrug - an overview | ScienceDirect Topics. (2020). Www.sciencedirect.com. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/prodrug

Research, C. for D. E. and. (2023). Drug Trials Snapshots: AZSTARYS. FDA. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-azstarys

Serdexmethylphenidate and dexmethylphenidate (oral route). (2025). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/serdexmethylphenidate-and-dexmethylphenidate-oral-route/description/drg-20510796#drug-side-effects

Serdexmethylphenidate; Dexmethylphenidate Capsules. (2023). Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/23699-serdexmethylphenidate-dexmethylphenidate-capsules

Staley, B. S., Robinson, L. R., Claussen, A. H., Katz, S. M., Danielson, M. L., Summers, A. D., Farr, S. L., Blumberg, S. J., & Tinker, S. C. (2024). Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023. MMWR. Morbidity and Mortality Weekly Report, 73(40), 890–895. https://doi.org/10.15585/mmwr.mm7340a1

Stanulović, V., Hodolic, M., Mitsikostas, D. D., & Papadopoulos, D. (2021). Drug tolerability: How much ambiguity can be tolerated? A systematic review of the assessment of tolerability in clinical studies. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15016

Teeter, L. A. (2023, April 27). Natural Remedies for Anxiety & Depression. Rupa Health. https://www.rupahealth.com/post/natural-remedies-for-anxiety-depression

Varanasi-Diaz, S. (2024, February 8). 10 Commonly Prescribed Medications and the Foods That Should Be Avoided with Them. Rupa Health. https://www.rupahealth.com/post/10-commonly-prescribed-medications-and-the-foods-that-should-be-avoided-with-them

Yoshimura, H. (2023, October 2). What causes ADHD?: Using lab testing and an integrative approach to understand the root cause. Rupa Health. https://www.rupahealth.com/post/what-causes-adhd-using-lab-testing-and-an-integrative-approach-to-understand-the-root-cause

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Neurological
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! 👋 Join Dr. Robert Silverman for an insightful webinar, "Food Sensitivities, GLP-1, and Gut Health" on April 2nd at 2 PM EST / 11 AM PST. In this session, you'll gain insight into how GLP-1 may play a role in gut function, metabolism, and immune response, how food sensitivities may be linked to digestive discomfort, and practical strategies to help support gut health and overall well-being. Register now to secure your spot!